These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25338999)

  • 1. In Silico docking studies of selected flavonoids--natural healing agents against breast cancer.
    Suganya J; Radha M; Naorem DL; Nishandhini M
    Asian Pac J Cancer Prev; 2014; 15(19):8155-9. PubMed ID: 25338999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico Molecular Modelling of Selected Natural Ligands and their Binding Features with Estrogen Receptor Alpha.
    Maruthanila VL; Elancheran R; Roy NK; Bhattacharya A; Kunnumakkara AB; Kabilan S; Kotoky J
    Curr Comput Aided Drug Des; 2019; 15(1):89-96. PubMed ID: 30306879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of leads targeting ER-α in breast cancer: An in silico exploration from natural domain.
    Ashtekar SS; Bhatia NM; Bhatia MS
    Steroids; 2018 Mar; 131():14-22. PubMed ID: 29307843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, and
    Choudhari RC; Kaur K; Das A; Jaitak V
    Curr Comput Aided Drug Des; 2024; 20(5):640-652. PubMed ID: 37888813
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Alamri A; Rauf A; Khalil AA; Alghamdi A; Alafnan A; Alshammari A; Alshammari F; Malik JA; Anwar S
    Biomed Res Int; 2021; 2021():9734279. PubMed ID: 34957309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational Exploration of Naturally Occurring Flavonoids as TGF-β Inhibitors in Breast Cancer: Insights from Docking and Molecular Dynamics Simulations and In-vitro Cytotoxicity Study.
    Shah U; Patel N; Patel M; Rohit S; Solanki N; Patel A; Patel S; Patel V; Patel R; Jawarkar RD
    Chem Biodivers; 2024 Jun; 21(6):e202301903. PubMed ID: 38623839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artonin E and Structural Analogs from Artocarpus Species Abrogates Estrogen Receptor Signaling in Breast Cancer.
    Etti I; Abdullah R; Hashim NM; Kadir A; Abdul AB; Etti C; Malami I; Waziri P; How CW
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27367662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Garlic Phytocompounds Possess Anticancer Activity by Specifically Targeting Breast Cancer Biomarkers - an in Silico Study.
    Roy N; Davis S; Narayanankutty A; Nazeem P; Babu T; Abida P; Valsala P; Raghavamenon AC
    Asian Pac J Cancer Prev; 2016; 17(6):2883-8. PubMed ID: 27356707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico molecular docking and dynamic simulation of eugenol compounds against breast cancer.
    Rasul HO; Aziz BK; Ghafour DD; Kivrak A
    J Mol Model; 2021 Dec; 28(1):17. PubMed ID: 34962586
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Rajagopal K; Kalusalingam A; Bharathidasan AR; Sivaprakash A; Shanmugam K; Sundaramoorthy M; Byran G
    Molecules; 2023 May; 28(10):. PubMed ID: 37241915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simulation studies, 3D QSAR and molecular docking on a point mutation of protein kinase B with flavonoids targeting ovarian Cancer.
    Ajjarapu SM; Tiwari A; Taj G; Singh DB; Singh S; Kumar S
    BMC Pharmacol Toxicol; 2021 Nov; 22(1):68. PubMed ID: 34727985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching from Aromatase Inhibitors to Dual Targeting Flavonoid-Based Compounds for Breast Cancer Treatment.
    Gobbi S; Martini S; Rozza R; Spinello A; Caciolla J; Rampa A; Belluti F; Zaffaroni N; Magistrato A; Bisi A
    Molecules; 2023 Mar; 28(7):. PubMed ID: 37049810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular docking and ¬in-silico study of natural antagonists of ER-alpha receptor: Potential candidates against breast cancer.
    Ahmed B; Qadir MI; Noor-Ul-Ain H
    Pak J Pharm Sci; 2020 Mar; 33(2):733-738. PubMed ID: 32276920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating a Library of Flavonoids as Potential Inhibitors of a Cancer Therapeutic Target MEK2 Using in Silico Methods.
    AlZahrani WM; AlGhamdi SA; Sohrab SS; Rehan M
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure Based Multitargeted Molecular Docking Analysis of Selected Furanocoumarins against Breast Cancer.
    Acharya R; Chacko S; Bose P; Lapenna A; Pattanayak SP
    Sci Rep; 2019 Oct; 9(1):15743. PubMed ID: 31673107
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Majumder R; Parida P; Paul S; Basak P
    Nat Prod Res; 2020 Aug; 34(16):2363-2366. PubMed ID: 30600703
    [No Abstract]   [Full Text] [Related]  

  • 17. Baicalein has protective effects on the 17β-estradiol-induced transformation of breast epithelial cells.
    Chen Y; Wang J; Hong DY; Chen L; Zhang YY; Xu YN; Pan D; Fu LY; Tao L; Luo H; Shen XC
    Oncotarget; 2017 Feb; 8(6):10470-10484. PubMed ID: 28060756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular docking simulation and in vitro studies on estrogenic activities of flavonoids from leaves of Carya cathayensis Sarg.
    Lu JJ; Zhou FM; Hu XJ; Fang JJ; Liu CX; Zhu BQ; Ding ZS
    Steroids; 2020 Nov; 163():108726. PubMed ID: 32889051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico Design, Synthesis and Bioactivity of N-(2, 4-Dinitrophenyl)-3-oxo- 3-phenyl-N-(aryl) Phenyl Propanamide Derivatives as Breast Cancer Inhibitors.
    Ramana M; Lokhande R; Bhar S; Ranade P; Mehta A; Gadre G
    Curr Comput Aided Drug Des; 2017; 13(2):112-126. PubMed ID: 28019636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multitargeted Molecular Docking Study of Natural-Derived Alkaloids on Breast Cancer Pathway Components.
    Singla R; Jaitak V
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):294-302. PubMed ID: 28382865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.